161
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Preparation and in vitro/in vivo evaluation of a clonidine hydrochloride drug–resin suspension as a sustained-release formulation

, , , , , & show all
Pages 394-402 | Received 11 Jul 2020, Accepted 01 Feb 2021, Published online: 09 Mar 2021

References

  • Alrabiah H, Attia S M, Al-Shakliah N S, et al. Development and validation of an HPLC-UV detection assay for the determination of clonidine in mouse plasma and its application to a pharmacokinetic study. Molecules. 2020;25(18):4109.
  • Davies DS, Wing LMH, Reid JL, et al. Pharmacokinetics and concentration–effect relationships of intervenous and oral clonidine. Clin Pharmacol Ther. 1977;21(5):593–601.
  • Westfall TC, Westfall DP. Adrenergic agonists and antagonists. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s the pharmacological basis of therapeutics. 12th ed. New York: McGraw-Hill; 2011.
  • Merino-Bohórquez V, Delgado-Valverde M, García-Palomo M, et al. Physicochemical and microbiological stability of two news oral liquid formulations of clonidine hydrochloride for pediatric patients. Pharm Dev Technol. 2019;24(4):465–478.
  • Bo-Hui X, Yu-bin W, Hong-Yan Z. Mini-tablet combination for sustained release of clonidine hydrochloride and hydrochlorothiazide: preparation and pharmacokinetics in beagle dogs. Pharmazie. 2016;71(2):76–83.
  • Bo-Hui X, Xue K, Qi-Neng P. Optimization of compound hydrochlorothiazide/clonidine hydrochloride sustained-release preparation by central composite design/response surface methodology. J China Pharm Univ. 2009;39(6):505–509.
  • Arenas-López S, Riphagen S, Tibby SM, et al. Use of oral clonidine for sedation in ventilated paediatric intensive care patients. Intensive Care Med. 2004;30(8):1625–1629.
  • Guo X, Chang RK, Hussain MA. Ion-exchange resins as drug delivery carriers. J Pharm Sci. 2009;98(11):3886–3902.
  • Mundada AS, Meshram DR, Banbale HB, et al. Formulation and evaluation of dispersible taste masked tablet of roxithromycin. Asian J Pharm. 2008;2(2):116–119.
  • Shah RB, Tawakkul MA, Sayeed VA, et al. Complexation between risperidone and amberlite resin by various methods of preparation and binding study. Drug Dev Ind Pharm. 2009;35(12):1409–1418.
  • Chang RK, Shinwari M, Leonzio M, et al. Evaluation of the disintegrant properties for an experimental, crosslinked polyalkylammonium polymer. Int J Pharm (Amsterdam). 1998;173(1–2):87–92.
  • Raghavan KS, Chang RK, Pang J, et al. Physical and chemical properties of DMP 504, a polyalkylammonium-based bile acid sequestrant. Pharm Dev Technol. 1997;2(3):233–241.
  • Martin GJ. Ion exchange and absorption agents in medicine. Am J Trop Med Hyg. 1955;4(6):1145–1145.
  • Xiang-Lu L, Yuan T, Tian-Rong Y, et al. Study of fluidized bed bottom gush coating technology. J Liaoning Univ Trad Chin Med. 2014;16(5):230–233.
  • Mehle A, Kitak D, Podrekar G, et al. In-line agglomeration degree estimation in fluidized bed pellet coating processes using visual imaging. Int J Pharm. 2018;546(1–2):78–85.
  • Hong-Fei L, Dan L, Cheng C, et al. Preparation and evaluation of carbinoxamine maleate sustained release suspensions with ion exchange resin as the carriers. Lat Am J Pharm. 2017;36(4):797–809.
  • Yan-Xun L, Cong-Cong L, Xiao-Qiang G, et al. Equilibrium solubility, preferential solvation and solvent effect study of clotrimazole in several aqueous co-solvent solutions. J Chem Thermodyn. 2020;151:106255.
  • Vemula SK, Veerareddy PR. Development, evaluation and pharmacokinetics of time-dependent ketorolac tromethamine tablets. Expert Opin Drug Deliv. 2013;10(1):33–45.
  • Vemula SK. Formulation and pharmacokinetics of colon-specific double-compression coated mini-tablets: chronopharmaceutical delivery of ketorolac tromethamine. Int J Pharm. 2015;491(1–2):35–41.
  • Yi-Dan W, Cong-Hao L, Qiang Z, et al. Comparison of thermosensitive in situ gels and drug–resin complex for ocular drug delivery: in vitro drug release and in vivo tissue distribution. Int J Pharm. 2020;578:119184.
  • Jun L, Fang C, Hong-Guo J, et al. Preparation of nabumetone suspension and preliminary study on its stability. West China J Pharm Sci. 2005;20(1):26–28.
  • Sana S, Rajani A, Sumedha N, et al. Formulation and evaluation of taste masked oral suspension of dextromethorphan hydrobromide. Int J Drug Dev Res. 2012;4(2):159–172.
  • Jian-Zhong Z, Jie G, Yan-Li M. Determination of cefpirome sulfate in human plasma by HPLC. Chin J Hosp Pharm. 2010;30(21):1875–1877.
  • Nilsson P, Hansson P. Ion-exchange controls the kinetics of deswelling of polyelectrolyte microgels in solutions of oppositely charged surfactant. J Phys Chem B. 2005;109(50):23843–23856.
  • Eichman ML. Drug–resin complexes stabilized by chelating agents. United States patent US 5,980,882. 1999 Sep 11.
  • Huan-Xiang Z, Gang C, Wei-San P, et al. Preparation of codeine-resinate and chlorpheniramine-resinate sustained-release suspension and its pharmacokinetic evaluation in beagle dogs. Drug Dev Ind Pharm. 2007;33(6):649–665.
  • Jin C, Hong-Fei L, Wei-San P, et al. The preparation of the sustained release metformin hydrochloride microcapsules by the Wurster fluidized bed. Pak J Pharm Sci. 2014;27(4):779–784.
  • Shelukar S, Ho J, Zega J, et al. Identification and characterization of factors controlling tablet coating uniformity in a Wurster coating process. Powder Technol. 2000;110(1–2):29–36.
  • Arimoto M, Ichikawa H, Fukumori Y. Microencapsulation of water-soluble macromolecules with acrylic terpolymers by the Wurster coating process for colon-specific drug delivery. Powder Technol. 2004;141(3):177–186.
  • Junyaprasert VB, Manwiwattanakul G. Release profile comparison and stability of diltiazem-resin microcapsules in sustained release suspensions. Int J Pharm. 2008;352(1–2):81–91.
  • Bhise MR, Narkhede MB, Mohod SP. Development and evaluation of extended release ambroxol HCl and guaifenesin suspension. Res J Pharm Technol. 2012;5(1):98–102.
  • Hao-Fan L, Lian-Dong H, Singh RP, et al. Fabrication of a novel drug–resin combination device for controlled release of dextromethorphan hydrobromide. Colloids Surf B Biointerfaces. 2020;189:110833.
  • Long-Yan H, Yi F, Sheng-De X. About the prescription optimization index of sustained and controlled release preparations. Chin J Tradit Chin Med. 2006;31(1):15–17.
  • Hong-Fei L, Cheng C, Dan L, et al. Preparation, evaluation and formulation optimization of sustained release microcapsuled ion-exchange resin beads containing ambroxol hydrochloride. Lat Am J Pharm. 2015;34(10):2054–2060.
  • Yang Q, Wen-Long L, Yuan-Rong X, et al. Development, optimization, and evaluation in vitro/in vivo of oral liquid system for synchronized sustained release of levodopa/benserazide. AAPS PharmSciTech. 2019;20(8):312.
  • Hong-Fei L, Shuang-Shuang S, Chang-Shan S, et al. Investigation of the pharmacokinetics of a novel sustained release metformin hydrochloride suspension with ion exchange resin as carriers in beagle dogs. Afr J Pharm Pharmacol. 2012;6(7):502–504.
  • Fu-Hong Q, Li Z, Yong-Tao Z, et al. Preparation and evaluation of a timolol maleate drug–resin ophthalmic suspension as a sustained-release formulation in vitro and in vivo. Drug Dev Ind Pharm. 2016;42(4):535–545.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.